The pharma industry has been facing various challenges in 2023, such as the aftermath of the COVID-19 pandemic, the rising costs of drug development, the increasing competition from generics and biosimilars, and the changing regulatory and reimbursement environment. As a result, some pharma companies have resorted to layoffs to reduce expenses, streamline operations, and focus on core growth areas.
Date | Company Name | Number of Layoffs | Reasons for Layoff |
Sept 28 | PTC Therapeutics | 25% of workforce | Restructuring and focus on R&D programs |
Sept 26 | Galecto | 70% of workforce | Lead lung disease asset failure and cash runway extension |
Sept 26 | AM-Pharma | Not specified | Workforce realignment after Phase III trial failure |
Sept 26 | Poxel | Significant(There are 15 employees at Poxel compared to 37 at the end of December 2022) | Financing for Phase II studies and resource constraints |
Sept 22 | ImmunityBio | ~50 employees | FDA approval failure and manufacturing issues |
Sept 19 | NightHawk Biosciences | 13 employees | Pivot to contract manufacturing for cost savings |
Sept 19 | Fresh Tracks Therapeutics | Most employees | Liquidation and dissolution due to strategic shift |
Sept 18 | Histogen | Most employees | Closure due to inability to enhance stockholder value |
Sept 18 | Kinnate Biopharma | 70% of employees | Reprioritization based on cash runway and pipeline focus |
Sept 15 | Lyndra Therapeutics | Nearly a quarter | Outsourcing and partnership strategy for future products |
Sept 12 | 2seventy bio | 40% of staff (176 employee) | Difficult macro environment, program delays, and cost savings |
Sept 11 | Enlivex Therapeutics | 50% of workforce | Focus on inflammatory and autoimmune indications |
Sept 6 | CSL Vifor | 85 employees | U.S. commercial business changes and synergy requirements |
Sept 5 | Infinity Pharmaceuticals | CEO, CMO, and more | Ongoing restructuring and merger breakdown |
Also Read: August Layoffs
Don’t miss out on our upcoming tracker update. We will be posting it every month. To get notified as soon as it’s ready, subscribe to our website’s notification system now.